Ajanta Pharma Limited — Tofacitinib Exporter Profile
Indian Pharmaceutical Exporter · #2 for Tofacitinib · $172.4K export value · DGFT Verified
Ajanta Pharma Limited is the #2 Indian exporter of Tofacitinib with $172.4K in export value and 36 verified shipments. Ajanta Pharma Limited holds a 4.4% market share in Tofacitinib exports across 5 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Tofacitinib Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Tofacitinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $50.0K | 1 | 31.8% |
| TANZANIA | $37.5K | 10 | 23.9% |
| UGANDA | $34.0K | 9 | 21.6% |
| KENYA | $32.1K | 14 | 20.5% |
| RWANDA | $3.4K | 2 | 2.2% |
Ajanta Pharma Limited exports Tofacitinib to 5 countries. The largest destination is IRAQ accounting for 31.8% of Ajanta Pharma Limited's Tofacitinib shipments, followed by TANZANIA (23.9%) and UGANDA (21.6%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tofacitinib from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SHAMS AL-THURAYA CO | IRAQ | $50.0K | 1 |
| HARLEYS LIMITED | KENYA | $32.1K | 14 |
| ASTRA PHARMA (T) LTD | TANZANIA | $31.5K | 8 |
| ABACUS PHARMA (A) LTD | UGANDA | $30.5K | 7 |
| ASTRA PHARMA T LTD | TANZANIA | $6.0K | 2 |
| ABACUS PHARMA A LIMITED-UGANDA | UGANDA | $3.5K | 2 |
| ABACUS PHARMA (A) LIMITED | RWANDA | $3.4K | 2 |
Ajanta Pharma Limited supplies Tofacitinib to 7 buyers globally. The largest buyer is SHAMS AL-THURAYA CO (IRAQ), followed by HARLEYS LIMITED (KENYA) and ASTRA PHARMA (T) LTD (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tofacitinib Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $1.2M worth of Tofacitinib through 814 shipments from 119 suppliers to 67 countries, serving 213 buyers globally. Ajanta Pharma Limited contributes $172.4K to this total, accounting for 4.4% of India's Tofacitinib exports. Ajanta Pharma Limited ships Tofacitinib to 5 countries through 7 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Tofacitinib Exports?
Ajanta Pharma Limited's average Tofacitinib shipment value is $4.8K per consignment, based on 36 shipments totaling $172.4K. The largest destination is IRAQ (31.8% of Ajanta Pharma Limited's Tofacitinib exports).
How Does Ajanta Pharma Limited Compare to Other Indian Tofacitinib Exporters?
Ajanta Pharma Limited ranks #2 among 119 Indian Tofacitinib exporters with a 4.4% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($450.0K), AJANTA PHARMA LIMITED ($172.4K), BABA AGENCIES ($163.4K). Ajanta Pharma Limited processed 36 shipments to 5 destination countries.
What Tofacitinib Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5 | $56.5K | 11 |
| XELTIN XR 11 (TOFACITINIB EXTENDED RELEASE TABS 11 MG)[9438PACKx3x10=283140 TABS]EACH FILM COATED EXTENDED AS PER INV | $50.0K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5MG][1980X3X10= 59400TABLETS]CONT:AS PERINVOICE | $7.4K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5MG][1980 X 3 X 10 = 59400 TABLETS]CONT:AS PER INVOICE | $6.7K | 1 |
| XELTIN TABLETS 5MG TOFACITINIB TABS 5 MG 1800PACKx3x10 54000 TABS EACH FILM COATED TAB CONT TOFACITINIB AS PER INV | $6.0K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABS 5 MG][1200PACKx3x10=36000 TABS][EACH FILM COATED TABS CONT:TOFACITINIB AS PER INV | $4.4K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABS 5 MG][1320packx3x10=39600 TABS]EACH FILM COATED TAB CONT:TOFACITINIB AS PER INV | $4.4K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5MG][1200PACKx3x10=36000 TABS]EACH FILMCOATED TAB CONT:TOFACITINIB AS PER INV | $3.8K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5MG][1000PAC X 3 X 10 = 30000 TABLETS]CONT:AS PER INVOICE | $3.5K | 1 |
| XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5MG][1000PAC X 3 X 10 = 30000 TABLETS]CONT.AS PER DOCUMENT | $3.5K | 1 |
Ajanta Pharma Limited exports 26 distinct Tofacitinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is XELTIN TABLETS 5MG[TOFACITINIB TABLETS 5 with 11 shipments worth $56.5K.
How Does Ajanta Pharma Limited Compare to Nearest Tofacitinib Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $450.0K | 9 | 2 | $50.0K |
| 2 | AJANTA PHARMA LIMITED ★ | $172.4K | 36 | 5 | $4.8K |
| 3 | BABA AGENCIES | $163.4K | 14 | 1 | $11.7K |
| 4 | CROIENT PHARMA PRIVATE LIMITED | $150.0K | 3 | 1 | $50.0K |
Ajanta Pharma Limited ranks #2 among 119 Indian Tofacitinib exporters. Average shipment value of $4.8K compared to the market average of $9.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and BABA AGENCIES.
Which Indian Ports Ship Tofacitinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 203 | 24.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 179 | 22.0% |
| DELHI AIR CARGO ACC (INDEL4) | 105 | 12.9% |
| DELHI AIR | 82 | 10.1% |
| Bombay Air Cargo | 31 | 3.8% |
| Bombay Air | 30 | 3.7% |
| NHAVA SHEVA SEA (INNSA1) | 21 | 2.6% |
| Delhi Air | 19 | 2.3% |
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Tofacitinib Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Tofacitinib, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tofacitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tofacitinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 36 individual customs records matching Ajanta Pharma Limited exporting Tofacitinib, covering 26 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 213+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tofacitinib Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Tofacitinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Tofacitinib Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tofacitinib. For current shipment-level data, contact TransData Nexus.